companydata.dkcompanydata.dk

PHARMA NORD EXPORT ApS: Financial statements 2015

CVR: 70996510

Source: annual report 2015, Danish Business Authority

01/01/2015 – 31/12/2015

PHARMA NORD EXPORT ApS (CVR 70996510) has filed annual accounts for 2015. In 2015, the company reported a gross profit of DKK 2,264,422 and a net result of DKK 3,155,255 compared with DKK 3,143,964 the year before. That is an increase of 17.4% compared with the year before. Equity in the 2015 report amounted to DKK 59,299,490. The solvency ratio was 75.8%.

Gross Profit
DKK 2,264,422
Profit/Loss
DKK 3,155,255
Equity
DKK 59,299,490
Total Assets
DKK 78,247,119

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2015-2.3 mio.3.2 mio.59.3 mio.-
2014-1.9 mio.3.1 mio.56.1 mio.-
2013-2.3 mio.6.3 mio.53 mio.-
2012-2.3 mio.6 mio.47.1 mio.-

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is PHARMA NORD EXPORT ApS?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2015

PHARMA NORD EXPORT ApS: The 2014 annual report is outMay 27, 2015

PHARMA NORD EXPORT ApS has published its annual report for 2014. Gross profit came to DKK 1,928,662, and the net result was DKK 3,143,964.

About PHARMA NORD EXPORT ApS

PHARMA NORD EXPORT ApS is a Danish company of the type Anpartsselskab based in Vejle, founded in 1982. The company is registered under the industry Engroshandel med andre fødevarer. The management consists of Eli Wallin. The board consists of Michael Christiani Havemann (chair) and Eli Wallin. The company is owned by PHARMCO II ApS and PharmCo III ApS. According to the 2025 annual report, the company had an average of 66 employees. In 2025, the company reported a gross profit of DKK 1,575,000 and a net result of DKK 11,516,000 compared with DKK 6,889,205 the year before. Equity in the 2025 report amounted to DKK 46,928,000.

Source: annual report 2025, Danish Business Authority